Yu Xia
CIK: 0001963544
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Summit Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026SMMT
Summit Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
35K shares- - Oct 21, 2025SMMT
Summit Therapeutics Inc.
Purchase(P)Indirect533.6K shares at avg. $18.74$10.0M - Jan 2, 2025SMMT
Summit Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
35K shares- - Jan 2, 2025SMMT
Summit Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
5.4K shares at avg. $9.18-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award(A) Stock Option (right to buy) | 35,000 | - | - | Direct |
| Oct 21, 2025 | SMMT Summit Therapeutics Inc. | Purchase(P) | 533,617 | $18.74 | $9,999,983 | Indirect |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | Award(A) Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | Award(A) Stock Option (right to buy) | 5,438 | $9.18 | - | Direct |
1-4 of 4 transactions
About Xia Yu
Xia Yu (SEC CIK 0001963544) files insider reports with the SEC as Director of Summit Therapeutics Inc. (SMMT).
Signal8 holds 3 ownership filings by Xia Yu, all Form 4s, filed between Jan 6, 2025 and Jan 6, 2026. Those filings report 4 transactions, from Jan 2, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Xia Yu's filings is in MIAMI, FL.
Recent filings by Xia Yu
Other insiders filing for Summit Therapeutics Inc. (SMMT)
- Anand Bhaskar, Chief Accounting Officer
- Zanganeh Mahkam, Co-Chief Executive Officer
- DUGGAN ROBERT W, Co-Chief Executive Officer
- Soni Manmeet Singh, COO and CFO
- Booth Robert F., Director
- Huber Jeff, Director